In addition, before exogenous contrast agents are studied in humans, a unique target protein present on melanoma cells and absent on healthy cells will need to be identified, such as galectin-3 or collagen XVII, which have recently been shown to be overexpressed in melanoma cells.281. This evidence concerns the gene LGALS3 and melanoma.